.png){kind=icon}
.png){kind=icon}
Return
Charting individualized pathways: IGF-1 and vitamin D in guiding personalized medicine for residual risk after AMI
.png){kind=icon}
PRE
AI
A
M
M
A
E
G
L
A
D
F
G
A
G
A
DOI：10.1016/j.pcad.2026.04.003.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• IGF-1 levels show a U-shaped association with CAD severity. • IGF-1 levels below the median are linearly associated with adverse outcomes. • Hypovitaminosis D and low IGF-1 together increase residual cardiovascular risk. • IGF-1 and vitamin D dysregulation may impair vascular recovery post-AMI.
Keywords:
IGF-1
vitamin D
CAD severity
residual cardiovascular risk
personalized medicine
Journal
IF:
7.6
Papers:
1.9K
Citations:
6.4K
Organization
Cited Papers